Quote | Cardiol Therapeutics Inc. (NASDAQ:CRDL)
Last: | $1.98 |
---|---|
Change Percent: | -1.04% |
Open: | $1.94 |
Close: | $1.98 |
High: | $2.02 |
Low: | $1.93 |
Volume: | 187,758 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Cardiol Therapeutics Inc. (NASDAQ:CRDL)
Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) (" Cardiol " or the " Company "), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatmen...
2024-06-26 06:30:06 ET B. Riley analyst issues BUY recommendation for CRDL on June 26, 2024 04:52AM ET. CRDL was trading at $2.12 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 2 - Buy recommendations . ...
Message Board Posts | Cardiol Therapeutics Inc. (NASDAQ:CRDL)
Subject | By | Source | When |
---|---|---|---|
Market seems to have liked the update today: | 12yearplan | investorshub | 03/29/2023 2:16:48 PM |
https://ih.advfn.com/p.php?pid=staticchart&s=NASDAQ%3ACRDL&p=1&t=17&width=2 | 12yearplan | investorshub | 01/20/2023 4:04:03 PM |
znewcar1: $CRDL 38% v882K c.715 f63,7M H.750 ML.4734 | znewcar1 | investorshangout | 12/10/2022 3:27:53 AM |
Filings says it all - lean and mean: | 12yearplan | investorshub | 11/11/2022 2:33:40 PM |
Yes, screamin' buy at historical lows.. | 12yearplan | investorshub | 11/10/2022 1:51:42 PM |
News, Short Squeeze, Breakout and More Instantly...
Cardiol Therapeutics Inc. Company Name:
CRDL Stock Symbol:
NASDAQ Market:
Cardiol Therapeutics Inc. Website:
Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) (" Cardiol " or the " Company "), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatmen...
2024-06-26 06:30:06 ET B. Riley analyst issues BUY recommendation for CRDL on June 26, 2024 04:52AM ET. CRDL was trading at $2.12 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 2 - Buy recommendations . ...
Toronto, Ontario--(Newsfile Corp. - June 25, 2024) - Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) (" Cardiol " or the " Company "), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatmen...